1
|
Santos PSDS, Granzotto FCN, Antunes HS, de Lima EM, Varanda RDF, Maccari K, Bezinelli LM, Melo WR, Junior LAVS, De Macedo LD, Eduardo FDP. Dentistry consensus on HSCT - Part III: Special topics - Dentistry on HSCT. Hematol Transfus Cell Ther 2023; 45:379-386. [PMID: 37328345 PMCID: PMC10499586 DOI: 10.1016/j.htct.2023.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Accepted: 04/17/2023] [Indexed: 06/18/2023] Open
Abstract
Patients undergoing hematopoietic stem cell transplantation (HSCT) might present acute and late toxicities and the oral tissues are frequently affected. With the survival increasing, patients show late and long-term morbidities, and there is an important association between the general and the oral health. The first and second parts of this Consensus have showed the importance of the adequacy of oral health in the pre-HSCT, and the main alterations and oral care during the period of admission for HSCT. This third part aims to review specific themes of post-HSCT dental care, such as graft-versus-host disease (GVHD) and the pediatric patient. It also aims to review pertinent subjects, both during the HSCT period and post-HSCT, concerning quality of life, pain, cost-effectiveness, and remote care. Based on this review, it is evident the importance of the work of the dental surgeon (DS) in the follow-up and treatment of the HSCT patient, always collaborating with the whole multidisciplinary team.
Collapse
Affiliation(s)
- Paulo Sérgio da Silva Santos
- Departamento de Cirurgia, Estomatologia, Patologia e Radiologia da Faculdade de Odontologia de Bauru da Universidade de São Paulo, Bauru, São Paulo, Brazil
| | | | - Héliton Spindola Antunes
- Coordenação de Pesquisa Clínica do Instituto Nacional do Câncer, Rio de Janeiro, Rio de Janeiro, Brazil
| | | | | | - Karina Maccari
- Serviço de Odontologia do Hospital de Amor, Barretos, São Paulo, Brazil
| | | | - Walmyr Ribeiro Melo
- Odontologia Hospitalar - Hospital Samaritano do Grupo Américas, São Paulo, Brazil
| | | | - Leandro Dorigan De Macedo
- Serviço de Odontologia e Estomatologia do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirao Preto, São Paulo, Brazil; Faculdade de Medicina de Ribeirão Preto-USP, Ribeirao Preto, São Paulo, Brazil
| | | |
Collapse
|
2
|
Bezinelli L, Eduardo F, Neves V, Correa L, Lopes R, Michel-Crosato E, Hamerschlak N, Biazevic M. Quality of life related to oral mucositis of patients undergoing haematopoietic stem cell transplantation and receiving specialised oral care with low-level laser therapy: a prospective observational study. Eur J Cancer Care (Engl) 2015; 25:668-74. [DOI: 10.1111/ecc.12344] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/21/2015] [Indexed: 11/27/2022]
Affiliation(s)
- L.M. Bezinelli
- Dentistry School; Universidade de São Paulo (FOUSP); São Paulo Brazil
- Department of Hematopoietic Stem Cell Transplantation; Hospital Israelita Albert Einstein (HIAE); São Paulo Brazil
| | - F.P. Eduardo
- Department of Hematopoietic Stem Cell Transplantation; Hospital Israelita Albert Einstein (HIAE); São Paulo Brazil
| | - V.D. Neves
- Dentistry School; Universidade de São Paulo (FOUSP); São Paulo Brazil
| | - L. Correa
- Dentistry School; Universidade de São Paulo (FOUSP); São Paulo Brazil
| | - R.M.G. Lopes
- Department of Hematopoietic Stem Cell Transplantation; Hospital Israelita Albert Einstein (HIAE); São Paulo Brazil
| | - E. Michel-Crosato
- Dentistry School; Universidade de São Paulo (FOUSP); São Paulo Brazil
| | - N. Hamerschlak
- Clinical Research Center; Department of Hematopoietic Stem Cell Transplantation; Hospital Israelita Albert Einstein (HIAE); São Paulo Brazil
| | - M.G.H. Biazevic
- Dentistry School; Universidade de São Paulo (FOUSP); São Paulo Brazil
| |
Collapse
|
3
|
Van Schandevyl G, Bauters T. Formulation of budesonide mouthwash for the treatment of oral chronic graft-versus-host disease. J Oncol Pharm Pract 2014; 22:82-5. [PMID: 25411262 DOI: 10.1177/1078155214560654] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Oral involvement is (very) common in chronic graft-versus-host disease and can cause discomfort and impairment of oral function. Budesonide, a highly potent corticosteroid with low systemic activity, can be used as a topical treatment for oral chronic graft-versus-host disease. We describe the development of a formulation of budesonide and sodium bicarbonate for use as mouthwash in patients with oral chronic graft-versus-host disease.
Collapse
Affiliation(s)
- Guy Van Schandevyl
- Department of Hematology and Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Belgium
| | - Tiene Bauters
- Department of Pharmacy, Ghent University Hospital, Belgium
| |
Collapse
|
4
|
Cleverson PATUSSI, Laurindo Moacir SASSI, Eduardo Ciliao MUNHOZ, Roberta Targa Stramandinoli ZANICOTTI, Juliana Lucena SCHUSSEL. Clinical assessment of oral mucositis and candidiasis compare to chemotherapic nadir in transplanted patients. Braz Oral Res 2014; 28:1-7. [DOI: 10.1590/1807-3107bor-2014.vol28.0050] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2013] [Accepted: 06/02/2014] [Indexed: 11/21/2022] Open
|